Benitec Biopharma Releases First Quarter 2027 Fiscal-Year Financial Results and Provides Operational Update

HAYWARD, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. NASDAQ:BNTC (“Benitec” or the “Company”), a clinical-stage biotechnology company developing disease-modifying genetic medicines for life-threatening, genetically defined diseases, based on its proprietary “Silence and Replace…